Treatments · Entity Annotation Prototype (beta)

1articles mentioning treatments

1treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: immune checkpoint-based therapies ×

immune checkpoint-based therapies

This treatment is selected. Its supporting articles are shown below.

immune checkpoint-based therapies1

Articles mentioning immune checkpoint-based therapies

1 articles · page 1 of 1

681 TNG260, a novel small-molecule CoREST inhibitor, sensitizes STK11-mutant tumors to anti-PD-1 therapy

jitc · abstract · 2025-11-04 · 1 matching annotations

78.5%

immune checkpoint-based therapies TNG260 pembrolizumab TNG260-induced NSCLC Non-small cell lung cancer NCT05887492

…tations (which account for ~20% of all cases) respond poorly to immune checkpoint-based therapies compared to STK11 wild-type lung cancers. Additionally, STK11 m…

Browse treatments

immune checkpoint-based therapies

Articles mentioning immune checkpoint-based therapies

681 TNG260, a novel small-molecule CoREST inhibitor, sensitizes STK11-mutant tumors to anti-PD-1 therapy